SecBot SecBot
PRESS-RELEASE ·Filed Mar 16, 2026

LFCR

Lifecore Biomedical, Inc.
MIXED
Impact 6/10
Horizonmonths Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

Traders should monitor whether 2026 revenue recovers beyond the guided range, as current outlook reflects near-term headwinds. Margin expansion and cost control are positives, but dependency on large customers creates execution risk. The ERP implementation and late-stage pipeline commercialization could be catalysts post-2026.

DirectionMixed
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$4.37
T+0 close · Mar 16, 2026 · via day close
Latest settled
+27.46%
T+60 · $5.57
Vs SPY
+16.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 16 $4.37entry
  2. T+1 · 8mo ago −0.23%α −0.50% · $4.36
  3. T+5 · 8mo ago −7.32%α −5.28% · $4.05
  4. T+20 · 7mo ago +18.99%α +15.21% · $5.20
  5. T+60 · 5mo ago +27.46%α +16.98% · $5.57
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lifecore Biomedical reported strong financial results for the seven-month transition period ending December 31, 2025, with revenue up 20% YoY to $75.5 million and Adjusted EBITDA more than quintupling to $13.1 million. Margins expanded significantly due to cost discipline and operational improvements, though net loss remains substantial. The company guided for $120–125 million in revenue for 2026, a decline from pro forma 2025 revenue of $141.4 million, citing customer-specific headwinds.

Key Financial Metrics

Revenue
$75.5M
+20.0% YoY
EPS
$-0.54
Guidance
$120M-$125M
lowered

Key Facts

  • Revenue for the seven-month transition period (May 26–Dec 31, 2025) was $75.5 million, up 20% YoY from $63.0 million.
  • Gross profit margin improved to 31.4% from 25.9% in the prior-year period, driven by operational initiatives.
  • Operating expenses fell 31% YoY to $24.4 million, primarily due to lower SG&A.
  • Adjusted EBITDA surged to $13.1 million from $2.6 million in the prior-year period.
  • Net loss narrowed to $18.0 million from $30.6 million, but remains significant.
  • Company guided 2026 revenue of $120–125 million, below 2025 pro forma revenue of $141.4 million, due to customer supply shifts and delayed launches.
  • Free cash flow was $3.6 million despite a $4.7 million preferred stock fee payment.
  • ERP system launched in January 2026 to support future efficiency.

Financial Impact

Revenue growth of 20% and Adjusted EBITDA up $10.5M YoY, but 2026 guidance implies a ~12% revenue decline from 2025 pro forma levels.

revenuegross marginoperating expensesAdjusted EBITDAnet lossfree cash flow

Risk Factors

  • Revenue guidance for 2026 is below 2025 pro forma levels, indicating near-term contraction.
  • High customer concentration: loss of key customers or delays in their programs significantly impact outlook.
  • $50.2 million in Series A Convertible Preferred Stock redemption risk starting June 2026, which could strain liquidity.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3256216

Track record

20 reports on LFCR

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +45.27% at T+60 after the Mar 26, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $6.42 Now $6.42 +0.08% settles Nov 18
  2. Nov 13, 20263d ago DEFM14A Neutral 6/10 Entry $6.42 Now $6.42 +0.00% settles Nov 17
  3. Nov 5, 202611d ago 8-K / DEFA14A Neutral 5/10 Entry $6.40 to $6.36 Now $6.42 +0.31% ▼ −0.63% −0.94% vs SPY
  4. Nov 4, 202612d ago 8-K Bearish 6/10 No price data
  5. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $6.44 to $6.40 Now $6.42 +0.31% ▲ +0.62% −3.79% vs SPY
  6. Oct 30, 202617d ago PREM14A Neutral 5/10 Entry $6.39 to $6.42 Now $6.42 +0.47% ▲ +0.47% +0.17% vs SPY
  7. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $6.37 to $6.37 Now $6.42 +0.78% · 0.00% +1.18% vs SPY
  8. Sep 28, 20267w ago SC 13D/A Bullish 7/10 Entry $6.59 to $6.58 Now $6.42 −2.58% ▼ −0.15% +0.05% vs SPY
  9. Sep 28, 20267w ago DEFA14A Bullish 7/10 Entry $6.52 to $6.59 Now $6.42 −1.53% ▲ +1.07% +1.26% vs SPY
  10. Sep 28, 20267w ago 8-K Bullish 8/10 Entry $6.52 to $6.59 Now $6.42 −1.53% ▲ +1.07% +1.26% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 16, 2026